Veterinary Vaccines Market, by Technology (Inactivated Vaccines, Toxoid Vaccines, Live Attenuated Vaccines, and Subunit and DNA Vaccines), by Animal Type (Companion (Equine, Canine, and Feline) and Livestock (Bovine, Ovine, Porcine, Poultry, and Others)),

Veterinary Vaccines Market, by Technology (Inactivated Vaccines, Toxoid Vaccines, Live Attenuated Vaccines, and Subunit and DNA Vaccines), by Animal Type (Companion (Equine, Canine, and Feline) and Livestock (Bovine, Ovine, Porcine, Poultry, and Others)), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

Veterinary/Animal vaccines are parenteral products that are used as prophylactic as well as in the treatment of various veterinary diseases. Veterinary vaccines play a crucial role in ensuring good health, longevity, and improving overall productivity of pets and livestock, in a cost-effective manner. It also plays an important role in curtailing incidence of transmission of various diseases from animals to humans.

Veterinary vaccines are broadly classified as inactivated vaccines, toxoid vaccines, live attenuated vaccines, conjugated vaccines, and subunit and DNA (Deoxyribonucleic acid) vaccines. Veterinary vaccines impact animal health and production quality and also ensure good health of general human population through consumption of various food procured from animals.

Market Dynamics

Growth of market is driven majorly by the increase in companion animal population, rising incidence of zoonotic diseases (diseases which are transferred from animals to people), initiatives by various government agencies and animal associations to maintain animal health, and the rising demand for animal-derived food products, which are driving growth of market. Moreover, increase in the prevalence of veterinary diseases is expected to drive the veterinary vaccine market growth during the forecast period. For instance, according to International Journal of Current Microbiology and Applied Sciences, as of July 10, 2020, number of cases of Sheep & Goat pox in India has increased from 913 cases per year to 3376 cases per year. Thus increasing prevalence of livestock diseases is expected to propel the market growth over the forecast period.

Key features of the study:

• This report provides in-depth analysis of the global veterinary vaccine market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022–2030), considering 2021 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global veterinary vaccine market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Aratana Therapeutics, Inc., Regeneus Ltd., Morphogenesis, Inc., Karyopharm Therapeutics, Inc., Zoetis, Inc., Eli Lilly and Company, Merck & Co., Inc., and Boehringer Ingelheim GmbH.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global veterinary vaccine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global veterinary vaccine market

Detailed Segmentation:

• Global Veterinary Vaccine Market, By Technology:
• Inactivated Vaccines
• Toxoid Vaccine
• Live Attenuated Vaccines
• Subunit and DNA Vaccines
• Global Veterinary vaccine Market, By Animal Type:
• Companion
• Equine
• Canine
• Feline
• Livestock
• Bovine
• Ovine
• Porcine
• Poultry
• Others
• Global Veterinary vaccine Market, By Region:
• North America
• By Country
• U.S.
• Canada
• Latin America
• By Country
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• Europe
• By Country
• Germany
• U.K.
• France
• Italy
• Spain
• Russia
• Rest of Europe
• Asia Pacific
• By Country
• China
• India
• Japan
• Australia
• South Korea
• ASEAN
• Rest of Asia Pacific
• Middle East
• By Country
• GCC
• Israel
• Rest of Middle East
• Africa
• By Region/Country
• South Africa
• Central Africa
• North Africa
• Company Profiles
• Aratana Therapeutics, Inc.*
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Market Strategies
• Regeneus Ltd.
• Morphogenesis, Inc.
• Karyopharm Therapeutics, Inc.
• Zoetis, Inc.
• Eli Lilly and Company
• Merck & Co., Inc.
• Boehringer Ingelheim GmbH

“*” marked represents similar segmentation in other categories in the respective section.